SynCore Biotechnology to Participate at the BIO-EUROPE Digital –Global Partnerships That Drive Life Science Dealmaking
SynCore Biotechnology will attend the BIO-EUROPE Digital –Global Partnerships [...]
SynCore Biotechnology Announces Interim Analysis Results for Novel Pancreatic Cancer Asset, SB05PC (EndoTAG®-1)
SynCore Biotechnology (4192:TT) receives interim analysis results for its [...]
SynCore Biotechnology to attend the 2020 BIO Asia-Taiwan Conference and Exhibition
SynCore Biotechnology (SynCore Bio) is pleased to announce that [...]
SynCore Biotechnology to attend the 2020 BIO International Convention
SynCore Biotechnology (SynCore Bio) is pleased to announce that [...]
SB05 Pancreatic Cancer Clinical Trial Reaches Conditions to Conduct Interim Analysis
SynCore’s global phase III clinical trial on pancreatic cancer [...]